Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human fibrinogen albumin microspheres
- Development stage
- Unknown
- Lead developer
- Kuaiyi Biopharmaceutical Technology
- Modality
- Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
**Human fibrinogen albumin microspheres** is an investigational intravenous platelet-substitute biologic developed by Kuaiyi Biopharmaceutical Technology for refractory thrombocytopenia. The product comprises human serum albumin microspheres bearing human fibrinogen on their surface. Surface fibrinogen is intended to bind platelet integrin alpha-IIb/beta-3, enabling the microspheres to bridge residual native platelets and promote platelet adhesion and aggregate formation to support hemostasis in patients with severe thrombocytopenia. The product, also called Fiplatezin, has been evaluated in a Phase III Chinese study following Phase IIb development.
- Other names
- Fiplatezinfibrinogen-albumin microspheresfreeze-dried human fibrinogen albumin microsphereslyophilized human fibrin-albumin microsphereslyophilized human fibrinogen-albumin microspheres
02
Targets
GPIIb/IIIa (Integrin alpha-IIb/beta-3)
Beyond the preview
Go deeper on human fibrinogen albumin microspheres.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human fibrinogen albumin microspheres.